Cyclophosphamide

NDC 65219-133 · Fresenius Kabi USA, LLC

Generic namecyclophosphamide

Dosage formINJECTION, POWDER, FOR SOLUTION

RouteINTRAVENOUS, ORAL

Active ingredient(s)CYCLOPHOSPHAMIDE

Strength2 g/100mL

Marketing categoryANDA

Packages

65219-133-20 — 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-133-20) / 100 mL in 1 VIAL, SINGLE-DOSE

J9075 — Injection, cyclophosphamide, not otherwise specified, 5 mg Medicare Part B payment limit (ASP + 6%): $0.57

FDA lists these products with the same active ingredient.

42806-902 — cyclophosphamide, 42806-903 — cyclophosphamide, 46708-618 — Cyclophosphamide, 46708-619 — Cyclophosphamide, 55150-270 — Cyclophosphamide, 55150-271 — Cyclophosphamide, 55150-272 — Cyclophosphamide, 62332-618 — Cyclophosphamide, 62332-619 — Cyclophosphamide, 65219-131 — cyclophosphamide, 65219-135 — cyclophosphamide, 68001-442 — cyclophosphamide, 68001-443 — cyclophosphamide, 68001-444 — cyclophosphamide, 68001-694 — cyclophosphamide, 68001-695 — cyclophosphamide, 68001-696 — cyclophosphamide, 68275-222 — Cyclophosphamide, 69097-516 — Cyclophosphamide, 69097-517 — Cyclophosphamide, +62 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.